Table 3.
Clinical outcome at 30 day and 1 year follow-up
| Current smokers (n = 391) | Non-smokers (n = 695) | OR, (95 % CI) | p | Adjusteda OR, (95 % CI) | p | |
|---|---|---|---|---|---|---|
| Ischemic complications at 30 day | ||||||
| Death | 2.3 % (9) | 6.6 % (46) | 0.33 (0.16–0.69) | 0.002 | 0.71 (0.32–1.54) | 0.38 |
| Death + reinfarction | 3.3 % (13) | 8.1 % (56) | 0.39 (0.21–0.73) | 0.002 | 0.81 (0.42–1.59) | 0.54 |
| Bleeding complications at 30 day | ||||||
| Stroke, hemorrhagic | 0 | 0 | ||||
| Major bleedings requiring transfusion | 1.8 % (7) | 2.2 % (15) | 0.82 (0.33–2.04) | 0.68 | 1.33 (0.48–3.70) | 0.58 |
| All bleedings | 7.4 % (29) | 10.8 % (75) | 0.66 (0.42–1.04) | 0.07 | 0.83 (0.51–1.36) | 0.46 |
| Ischemic complications at 1 year | ||||||
| Death | 3.3 % (13) | 9.5 % (66) | 0.33 (0.18–0.6) | 0.0001 | 0.71 (0.37–1.36) | 0.30 |
CI confidence interval, OR odds ratio
aAdjusted for age and gender